Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?
Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem on their hands. After reporting their third-quarter earnings, shares of both ...
Hong Kong approves celebrity weight-loss drug, but experts say it’s not just to look good
The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...
Is Viking Therapeutics a Buy on the Dip?
Viking Therapeutics (NASDAQ: VKTX) soared to center stage earlier this year as a potentially promising player in one of today ...
Woman Dies After Using Weight-Loss Drug In U.K.’s First Case
A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...
New Drug CagriSema May Lead to 10% More Weight Loss Than Wegovy or Ozempic
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...
Yahoo22h
A stronger Ozempic, a Boeing supplier in trouble, and a simpler Starbucks: Business news roundup
Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday. The ...
Hims & Hers: Undeservedly Undervalued
Analyzing H&H's Q3 results and investment strategy in the healthcare industry, highlighting undervaluation and raising the ...